Pityriasis rosea - Revision history

Rossdonaldson1: /* Background */

2024-12-11T17:28:37Z

Background

← Older revision		Revision as of 17:28, 11 December 2024
Line 1:		Line 1:
	==Background==		==Background==
			{{Skin anatomy background images}}
	*Mild inflammatory exanthem		*Mild inflammatory exanthem
	**May be caused by HHV 6 and 7		**May be caused by HHV 6 and 7

2023-03-29T20:59:52Z

Disposition

2023-03-29T20:59:29Z

Differential Diagnosis

← Older revision		Revision as of 20:59, 29 March 2023
Line 27:		Line 27:
	**Also has fine scaling but KOH is diagnostic		**Also has fine scaling but KOH is diagnostic

	{{~~Generalized rash~~ DDX}}		{{Plaques DDX}}

	==Management==		==Management==

2019-10-06T19:56:05Z

References

2019-09-28T01:07:49Z

Evaluation

← Older revision		Revision as of 01:07, 28 September 2019
Line 11:		Line 11:
	[[File:Pityriasisfront.jpg\|thumb\|Pityriasis rosea on front]]		[[File:Pityriasisfront.jpg\|thumb\|Pityriasis rosea on front]]
	[[File:Heraldpatch2.jpg\|thumb\|Herald patch]]		[[File:Heraldpatch2.jpg\|thumb\|Herald patch]]
	*Begins with single, "herald," patch (salmon-colored, fine scaling)		*Begins with single, "herald,"[[rash\|patch]] (salmon-colored, fine scaling)
	**1-2 weeks prior to generalized eruption		**1-2 weeks prior to generalized eruption
	**Larger lesion (Herald Patch) that resembles the later smaller lesions		**Larger lesion (Herald Patch) that resembles the later smaller lesions

2019-09-15T22:37:46Z

Management

← Older revision		Revision as of 22:37, 15 September 2019
Line 34:		Line 34:
	*Natural sunlight may speed up resolution		*Natural sunlight may speed up resolution
	*Pruritus<ref>Richard P. Usatine and Jennifer Krejci-Manwaring: Rakel: Textbook of Family Medicine, 8th ed., Saunders 2011, (Ch) 33:p720</ref>		*Pruritus<ref>Richard P. Usatine and Jennifer Krejci-Manwaring: Rakel: Textbook of Family Medicine, 8th ed., Saunders 2011, (Ch) 33:p720</ref>
	**Antihistamine, topical steroids		**[[Antihistamine]], [[topical steroids]]
	***Triamcinolone 0.1% - Adults		***[[Triamcinolone]] 0.1% - Adults
	***Hydrocortisone 1% - Children		***[[Hydrocortisone]] 1% - Children
	**Other		**Other
	***Zinc oxide		***Zinc oxide

2019-07-04T06:00:18Z

Management

← Older revision		Revision as of 06:00, 4 July 2019
Line 36:		Line 36:
	**Antihistamine, topical steroids		**Antihistamine, topical steroids
	***Triamcinolone 0.1% - Adults		***Triamcinolone 0.1% - Adults
	***Hydrocortisone 1% - ~~children)~~		***Hydrocortisone 1% - Children
	**Other		**Other
	***Zinc oxide		***Zinc oxide

2017-03-01T16:18:05Z

Reverted edits by Neil.m.young (talk) to last revision by ClaireLewis

← Older revision		Revision as of 16:18, 1 March 2017
Line 2:		Line 2:
	*Mild inflammatory exanthem		*Mild inflammatory exanthem
	**May be caused by HHV 6 and 7		**May be caused by HHV 6 and 7
	**70% preceded by URI <ref> Sharma PK, Yadav TP, Gautam RK, Taneja N, Satyanarayana ~~left~~ (2000). "Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial". Journal of the American Academy of Dermatology 42 (2 Patient 1): 241–4. PMID 1064267 </ref>		**70% preceded by URI <ref> Sharma PK, Yadav TP, Gautam RK, Taneja N, Satyanarayana L (2000). "Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial". Journal of the American Academy of Dermatology 42 (2 Patient 1): 241–4. PMID 1064267 </ref>
	*Most common 10-35yr old		*Most common 10-35yr old
	*Not contagious		*Not contagious

2017-02-28T00:46:46Z

Text replacement - " L " to " left "

← Older revision		Revision as of 00:46, 28 February 2017
Line 2:		Line 2:
	*Mild inflammatory exanthem		*Mild inflammatory exanthem
	**May be caused by HHV 6 and 7		**May be caused by HHV 6 and 7
	**70% preceded by URI <ref> Sharma PK, Yadav TP, Gautam RK, Taneja N, Satyanarayana L (2000). "Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial". Journal of the American Academy of Dermatology 42 (2 Patient 1): 241–4. PMID 1064267 </ref>		**70% preceded by URI <ref> Sharma PK, Yadav TP, Gautam RK, Taneja N, Satyanarayana left (2000). "Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial". Journal of the American Academy of Dermatology 42 (2 Patient 1): 241–4. PMID 1064267 </ref>
	*Most common 10-35yr old		*Most common 10-35yr old
	*Not contagious		*Not contagious

2016-10-05T05:12:10Z

Evaluation

← Older revision		Revision as of 05:12, 5 October 2016
Line 17:		Line 17:
	*Secondary maculopapular rash with plaques following Langer Lines ("Christmas tree" pattern)		*Secondary maculopapular rash with plaques following Langer Lines ("Christmas tree" pattern)
	**Typically follows rip distribution		**Typically follows rip distribution
	*Pruritus can be moderate to severe		*[[Pruritus]] can be moderate to severe
	*Consider RPR or VDRL to rule out syphilis		*Consider RPR or VDRL to rule out syphilis